1984
DOI: 10.1007/bf00630293
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic and pharmacodynamic modelling with pancuronium

Abstract: The pharmacokinetics and pharmacodynamics of pancuronium were studied following intravenous infusion in eleven patients undergoing surgical anaesthesia. Measurement of the plasma concentrations (Cp) of the neuromuscular blocking agent ( NMBA ) and the concomitant intensities of paralysis allowed their simultaneous modelling. The pharmacokinetic parameters derived for pancuronium were in the range of previously reported values, except that the mean total systemic plasma clearance (0.79 +/- 0.28 ml X min-1 X kg-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
7
0

Year Published

1994
1994
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 28 publications
1
7
0
Order By: Relevance
“…Pharmacokinetic data that was below the detection limit of the LC–MS method were not included in statistical analyses. Hemodynamic data as a function of resulting plasma dobutamine concentration was correlated to sigmoidal distributions (Prism 5.04; GraphPad, La Jolla, California), which yielded minimum and maximum effects and the plasma concentration at 50% effect (EC 50 ) 19,20. Hemodynamic data taken with the Sequential Multiple Dosing Protocol were similarly fit to sigmoidal curves, which yielded a maximum effect and dose at 50% effect (ED 50 ).…”
Section: Methodsmentioning
confidence: 99%
“…Pharmacokinetic data that was below the detection limit of the LC–MS method were not included in statistical analyses. Hemodynamic data as a function of resulting plasma dobutamine concentration was correlated to sigmoidal distributions (Prism 5.04; GraphPad, La Jolla, California), which yielded minimum and maximum effects and the plasma concentration at 50% effect (EC 50 ) 19,20. Hemodynamic data taken with the Sequential Multiple Dosing Protocol were similarly fit to sigmoidal curves, which yielded a maximum effect and dose at 50% effect (ED 50 ).…”
Section: Methodsmentioning
confidence: 99%
“…There are a variety of examples in the literature that suggest this type of pharmacokinetic/ pharmacodynamic relationship as reported in Table 3 [80102, 313317, and 330]. A clockwise hysteresis may mechanistically manifest due to a variety of underlying mechanisms as discussed below.…”
Section: Clockwise Hysteresismentioning
confidence: 99%
“…This difference emphasizes the predominant influence of the context-sensitive half-life over the T ½ of the effect compartment, where the value in table 1 reflects the lack of pharmacokinetic influence, the relative purity of the effect compartment with the isolated arm technique, in the derivation of the "intrinsic" value for the rate constant. Atracurium Non-compartmental [11] 0.07 6.1 1.4 Two-compartment [12] 0.12 4.6 1.6 Two-compartment [13] 0.10 4.3 1.7 Non-compartmental [14] 0.12 3.4 1.8 Vecuronium Three-compartment [15] 0.10 5.5 1.5 Three-compartment [16] 0.17 5.8 1.5 Two-and three-compartment [17] 0.06 5.3 1.5 Non-compartmental [17] 0.09 3.9 1.8 Three-compartment [18] 0.11 --Rocuronium Three-compartment [19] 0.12 5.0 1.5 Pancuronium Two-and three-compartment [18] 0.48 5.5 1.5 Three-compartment [19] 0.11 4.8 1.6 Three-compartment [20] 0.15 --…”
Section: Discussionmentioning
confidence: 99%